<?xml version="1.0" ?>
<rss xmlns:ns0="http://www.itunes.com/dtds/podcast-1.0.dtd" version="2.0">
  <channel>
    <title>The GLP-1 Research Digest</title>
    <link>https://Dc1616DC.github.io/glp1-research-podcast</link>
    <description>Weekly analysis of the latest GLP-1 and obesity medication research. Hosted by Dan (registered dietitian) and Alex (science journalist).</description>
    <language>en-us</language>
    <lastBuildDate>Wed, 21 Jan 2026 17:09:30 +0000</lastBuildDate>
    <ns0:author>GLP-1 Research Digest</ns0:author>
    <ns0:summary>Weekly analysis of the latest GLP-1 and obesity medication research for healthcare professionals and informed patients.</ns0:summary>
    <ns0:explicit>no</ns0:explicit>
    <ns0:category text="Health &amp; Fitness">
      <ns0:category text="Nutrition"/>
    </ns0:category>
    <item>
      <title>Heart Health Research Digest - 2026-01-21</title>
      <description>This episode covers: Associations Between the Cardiovascular Health Diet Index (CHDI) and Cardiometabolic Risk Factors in; 2026 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass; Lifestyle factors and cardiometabolic risk.; Evaluating Cardiovascular Disease Risk.; Berberine Reduces Atrial Lipotoxicity and Endoplasmic Reticulum Stress to Alleviate Heart Failure Wi</description>
      <pubDate>Wed, 21 Jan 2026 17:09:30 +0000</pubDate>
      <guid isPermaLink="false">glp1-research-podcast-20260121170930</guid>
      <enclosure url="https://raw.githubusercontent.com/Dc1616DC/glp1-research-podcast/main/episodes/heart-health-2026-01-21.mp3" type="audio/mpeg" length="11398626"/>
      <ns0:duration>11:52</ns0:duration>
      <ns0:summary>This episode covers: Associations Between the Cardiovascular Health Diet Index (CHDI) and Cardiometabolic Risk Factors in; 2026 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass; Lifestyle factors and cardiometabolic risk.; Evaluating Cardiovascular Disease Risk.; Berberine Reduces Atrial Lipotoxicity and Endoplasmic Reticulum Stress to Alleviate Heart Failure Wi</ns0:summary>
      <ns0:explicit>no</ns0:explicit>
    </item>
    <item>
      <title>GLP-1 Research Digest - 2026-01-21</title>
      <description>This week's research roundup covers: Nutritional and lifestyle supportive care recommendations for management of obesity with GLP-1 - bas; Micronutrient and Nutritional Deficiencies Associated With GLP-1 Receptor Agonist Therapy: A Narrati; GLP-1 physiology and pharmacology along the gut-brain axis.; Development of a Follow-Up Protocol for Patients Treated with Injectable Semaglutide for Weight Loss; Target trial emulations for tirzepatide, semaglutide and SGLT2-inhibitors for dementia in patients w</description>
      <pubDate>Wed, 21 Jan 2026 14:53:20 +0000</pubDate>
      <guid isPermaLink="false">glp1-research-podcast-20260121145320</guid>
      <enclosure url="https://raw.githubusercontent.com/Dc1616DC/glp1-research-podcast/main/episodes/glp1-digest-2026-01-21.mp3" type="audio/mpeg" length="10588622"/>
      <ns0:duration>11:01</ns0:duration>
      <ns0:summary>This week's research roundup covers: Nutritional and lifestyle supportive care recommendations for management of obesity with GLP-1 - bas; Micronutrient and Nutritional Deficiencies Associated With GLP-1 Receptor Agonist Therapy: A Narrati; GLP-1 physiology and pharmacology along the gut-brain axis.; Development of a Follow-Up Protocol for Patients Treated with Injectable Semaglutide for Weight Loss; Target trial emulations for tirzepatide, semaglutide and SGLT2-inhibitors for dementia in patients w</ns0:summary>
      <ns0:explicit>no</ns0:explicit>
    </item>
    <item>
      <title>GLP-1 Research Digest - 2026-01-21</title>
      <description>This week's research roundup covers: Nutritional and lifestyle supportive care recommendations for management of obesity with GLP-1 - bas; Micronutrient and Nutritional Deficiencies Associated With GLP-1 Receptor Agonist Therapy: A Narrati; GLP-1 physiology and pharmacology along the gut-brain axis.; Development of a Follow-Up Protocol for Patients Treated with Injectable Semaglutide for Weight Loss; Target trial emulations for tirzepatide, semaglutide and SGLT2-inhibitors for dementia in patients w</description>
      <pubDate>Wed, 21 Jan 2026 13:03:24 +0000</pubDate>
      <guid isPermaLink="false">glp1-research-podcast-20260121130324</guid>
      <enclosure url="https://raw.githubusercontent.com/Dc1616DC/glp1-research-podcast/main/episodes/glp1-digest-2026-01-21.mp3" type="audio/mpeg" length="10086653"/>
      <ns0:duration>10:30</ns0:duration>
      <ns0:summary>This week's research roundup covers: Nutritional and lifestyle supportive care recommendations for management of obesity with GLP-1 - bas; Micronutrient and Nutritional Deficiencies Associated With GLP-1 Receptor Agonist Therapy: A Narrati; GLP-1 physiology and pharmacology along the gut-brain axis.; Development of a Follow-Up Protocol for Patients Treated with Injectable Semaglutide for Weight Loss; Target trial emulations for tirzepatide, semaglutide and SGLT2-inhibitors for dementia in patients w</ns0:summary>
      <ns0:explicit>no</ns0:explicit>
    </item>
  </channel>
</rss>